New drug for treating migraine pain may suit more people than existing medications

The drug, ubrogepant, relieved migraine pain within two hours for a fifth of people given it in a large-scale clinical trial led by Montefiore Headache Center in New York.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news